Trial Watch: Inhibiting PARP enzymes for anticancer therapy - Molecular & Cellular Oncology Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, June 18, 2016

Trial Watch: Inhibiting PARP enzymes for anticancer therapy - Molecular & Cellular Oncology



open access

 June 10, 2016

ABSTRACT

Introduction

PARP activity and cancer

PARP1 in cancer therapy

Clinical investigation of PARP inhibitors

Concluding remarks

Table 2. Ongoing clinical trials recently launched to evaluate the safety and efficacy of PARP inhibitors in cancer patients.

0 comments :

Post a Comment

Your comments?